Potential Mechanism Associated with Post–Heart Transplantation Diabetes Mellitus in Chinese Patients
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf071 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Xiao Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Heart Transplantation, Diabetes Mellitus, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Chinese Pharmaceutical Association Hospital Pharmacy department, National Natural Science Foundation of China, Hubei Provincial Key Research and Development Program.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Posttransplantation diabetes mellitus (PTDM) is a common metabolic complication following heart transplantation (HT), which not only leads to elevated microvascular morbidity, but also seriously affects graft function and recipient survival. However, the specific metabolites and underlying mechanisms are not yet fully understood.
Objective
This study aimed to preliminarily screen out differentially expressed metabolites that are associated with PTDM in HT recipients and elucidate its potential pathophysiological mechanisms by using a global metabolomics approach, and provide a basis for the management of PTDM.
Methods
A total of 106 adult HT recipients (56 PTDM and 50 non-PTDM) who were followed for more than 1 year were enrolled in the study. Untargeted metabolomics was performed by ultra-high-performance liquid chromatography–tandem mass spectrometry. Demographics, clinical data, and drug information were collected at the time of sample collection.
Results
PTDM patients were older (P = .003), with higher body mass index scores (P = .010), higher triglyceride levels (P = .007), and a higher prevalence of hypertension (P = .001) than non-PTDM patients. A total of 1174 metabolites were detected, of which 99 metabolites showed significantly differentially abundant (VIP > 1; P < .05; FC > 1.5 or <0.67). KEGG functional enrichment analysis showed these differently expressed metabolites could be further enriched in ABC transporter, carbon metabolism, retrograde endocannabinoid signaling, and phospholipase D signaling pathway. Compared with the non-PTDM group, glutamate, diacylglycerol, and D-sorbitol were significantly changed in PTDM through metabolomics.
Conclusion
These findings may provide a novel understanding of the pathological mechanism of PTDM and could be used to predict the development and progression of PTDM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China.
Förderung
- Chinese Pharmaceutical Association Hospital Pharmacy department
- National Natural Science Foundation of China
- Hubei Provincial Key Research and Development Program
Zitieren
APA
Huang, X., Xu, Q., Chen, L., Liu, L., Zhou, Y., Zhou, H., & Zhang, Y. (2025). Potential Mechanism Associated with Post–Heart Transplantation Diabetes Mellitus in Chinese Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf071
Vancouver
Huang X, Xu Q, Chen L, Liu L, Zhou Y, Zhou H, et al. Potential Mechanism Associated with Post–Heart Transplantation Diabetes Mellitus in Chinese Patients. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf071
BibTeX
@article{Huang2025,
author = {Huang, Xiao and Xu, Qiling and Chen, Linhua and Liu, Li and Zhou, Ying and Zhou, Hong and Zhang, Yu},
title = {Potential Mechanism Associated with Post–Heart Transplantation Diabetes Mellitus in Chinese Patients},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf071}
}
EUVIMED